SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $10,000 | -47.4% | 137 | 0.0% | 0.00% | -62.5% |
Q3 2019 | $19,000 | -24.0% | 137 | 0.0% | 0.01% | -20.0% |
Q2 2019 | $25,000 | +13.6% | 137 | 0.0% | 0.01% | +25.0% |
Q1 2019 | $22,000 | +69.2% | 137 | 0.0% | 0.01% | +33.3% |
Q4 2018 | $13,000 | -31.6% | 137 | 0.0% | 0.01% | -14.3% |
Q3 2018 | $19,000 | -9.5% | 137 | 0.0% | 0.01% | -22.2% |
Q2 2018 | $21,000 | -4.5% | 137 | 0.0% | 0.01% | -10.0% |
Q1 2018 | $22,000 | -4.3% | 137 | 0.0% | 0.01% | -9.1% |
Q4 2017 | $23,000 | +155.6% | 137 | 0.0% | 0.01% | +120.0% |
Q3 2017 | $9,000 | -18.2% | 137 | 0.0% | 0.01% | -16.7% |
Q2 2017 | $11,000 | +10.0% | 137 | 0.0% | 0.01% | 0.0% |
Q1 2017 | $10,000 | – | 137 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |